We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Investigates the ancillary strengthening of the peripheral surveillance systems during short-term interventions
Findings from 63 interviews with patients, caregivers, health care providers and members of communities
Rapid diagnostic methods are essential in control of Ebola outbreaks
Discusses targets to meet the needs of HIV-exposed and HIV-infected children
Assess follow-up and programmatic outcomes of HIV-exposed infants at Martin Preuss Centre, Lilongwe
Visited households in 60 randomly selected villages in Ca Mau province, Vietnam
Extensively drug-resistant tuberculosis (XDR-TB) represents an emerging public health problem worldwide
Trypanosoma cruzi is the causative agent of Chagas disease, and infects 5-8 million people in Latin America
Trypanosoma cruzi assay protocols were evaluated to understand the parameters influencing drug susceptibility
Chagas disease is endemic in Latin America and spreading around the globe due to human migration
Article in the Journal of Molecular Diagnostics
The leishmaniases are protozoal diseases that affect large populations in tropical and subtropical regions
This work describes a possible new, sensitive and specific marker.
Phase II randomized trial
Journal article in Reproductive Toxicology
Parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine
This study explored the genotoxicity of flubendazole and its main metabolites, and tested a new oral formulation
Meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data
This is a study in children under 5 years in sub-Saharan Africa. It is a randomised, multicentre, phase 4 trial
This article describes the early stage evaluation of a free on-line tool known as Site-Finder the Global Health Network
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).